ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
30 announcements with these filters
Arvaya Healthcare Limited held its 41st Annual General Meeting on 21st September 2026, where members adopted financial statements and approved material related party transactions.
Arvaya Healthcare has incorporated a wholly-owned subsidiary, Arvaya Insurance Broking Private Limited, for an investment of ₹0.80 Crore. This entity will provide insurance broking services.
Arvaya Healthcare Limited has dispatched web links to shareholders for accessing the Notice of its 41st Annual General Meeting and the Annual Report.
Arvaya Healthcare filed its 41st Annual Report for FY 2025-26, including the notice for the Annual General Meeting scheduled on 21 September 2026.
Arvaya Healthcare Limited issued a Notice of its 41st Annual General Meeting to be held on 21 September 2026 via video conferencing. The agenda includes approval for material related party transactions.
Arvaya Healthcare Limited approved the acquisition of a Copyright and Intellectual Property portfolio from Defib Institute of Health Solutions LLP for a consideration of ₹10 Crores.
Arvaya Healthcare Limited scheduled a board meeting for August 26, 2026, to discuss a related party transaction regarding the acquisition of a business undertaking.
Arvaya Healthcare Limited submitted the voting results and the Scrutinizer's Report for its recent Postal Ballot. The company confirmed that all 6 resolutions were successfully passed.
Arvaya Healthcare Limited plans to incorporate a new wholly-owned subsidiary to operate in the insurance broking service sector. The company will hold 100% equity stake.
Arvaya Healthcare Limited has informed the exchange that the Statement of Deviation or Variation under Regulation 32 is not applicable for the quarter ended June 2026.
Arvaya Healthcare Ltd reported revenue from operations of ₹29.9 Cr and net profit of ₹0.5 Cr for Q1 FY27.
Arvaya Healthcare scheduled a Board Meeting for August 12, 2026, to consider financial results, AGM proceedings, and various appointments.
Arvaya Healthcare Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026. This submission complies with SEBI Regulation 31(1)(b) requirements.
Arvaya Healthcare Limited issued a Postal Ballot notice for shareholders to approve the acquisition of Sushodha Institute of Gastroenterology. Voting ends on August 13, 2026.
Arvaya Healthcare approved a Rs. 15.49 Crore preferential issue of 3,871,854 equity shares. The issue price is set at Rs. 40 per share for 47 investors.
Arvaya Healthcare will acquire Sushodha Institute of Gastroenterology for Rs.15.49 Crore via share swap. The 100% stake acquisition expands its specialized healthcare footprint in India.
Arvaya Healthcare approved the 100% acquisition of SIGPL for Rs. 15.49 Crore via share swap. The board also proposed a Rs. 210 Crore rights issue.
Bijoy Hans Ltd is now Arvaya Healthcare Limited, effective July 13, 2026. The BSE has updated its records and Scrip ID to ARVAYA.
Arvaya Healthcare Ltd appointed Mr. Bidari Kotresh Anilkumar as Executive Director. The appointment, effective July 4, 2026, requires shareholder approval.
Arvaya Healthcare scheduled a board meeting for July 4, 2026. The board will consider appointing Mr. Bidari Kotresh Anilkumar as Executive Director.
Arvaya Healthcare Limited received BSE approval to reclassify four promoter group members as public shareholders. The outgoing promoters held 0% shares.
Arvaya Healthcare Limited issued a corrigendum to correct EPS errors in its FY26 financial results. The update ensures accurate reporting of earnings data for investors.
Arvaya Healthcare Limited exceeded SEBI LODR exemption thresholds on March 4, 2026. The company will now comply with applicable corporate governance and secretarial reporting norms.
Bijoy Hans Ltd reported revenue from operations of ₹9.1 Cr and net profit of ₹1.5 Cr for Q4 FY26.
Arvaya Healthcare Limited reported audited financial results for the fiscal year ended March 31, 2026. The company also announced the appointment of new internal auditors.
Arvaya Healthcare Limited scheduled a board meeting for May 28, 2026. Directors will consider and approve audited financial statements for the fiscal year ended March 2026.
Bijoy Hans Limited has officially changed its name to Arvaya Healthcare Limited following MCA approval. The amendment to its Memorandum and Articles of Association is effective immediately.
Bijoy Hans Ltd has designated its Audit Committee as the primary body for 'Those Charged with Governance' (TCWG) per NFRA guidelines. The Board also appointed CFO Mr. Ranganath Abhiram as Nodal Officer and adopted a two-way communication framework policy with statutory auditors. These steps aim to strengthen audit-related communications and corporate governance compliance.
Bijoy Hans Ltd has received trading approval from BSE for 4,05,21,836 equity shares issued on a preferential basis to promoters and non-promoters. The approval, dated April 22, 2026, makes these shares effective for trading from April 23, 2026.
Bijoy Hans Limited announced the results of its postal ballot where nine resolutions were passed with the requisite majority. Key resolutions included a name change to Arvaya Healthcare Limited, increasing borrowing limits, and revising director remuneration. All eight special resolutions and one ordinary resolution were successfully approved by shareholders.